The efficacy of silver proteinate in the treatment of acute nasopharyngitis

Author:

Sobolev V. P.1,Svistushkin V. M.1,Leyzerman M. G.2,Magomedov K. R.2,Bidanova D. B.1,Budagova G. N.1

Affiliation:

1. Sechenov First Moscow State Medical University (Sechenov University)

2. Bauman City Clinical Hospital No. 29

Abstract

Acute nasopharyngitis is the most common reason for visit a doctor, usually benign, self-limited disease. It is also characterized by a high frequency of complications in children and nonspecific symptoms that require special care from the doctor when examining patients. The clinical and social significance of acute nasopharyngitis is due to their high prevalence, and inadequate treatment leads to a protracted course or to a transition to a chronic one. The relevance of this problem adds to the presence of a large number of various drugs, but not many drugs have evidence-based effectiveness. In the treatment of acute nasopharyngitis local drugs are very important. The drug is a silver proteinate agent with broad antibacterial anti-inflammatory activity. The drug is used to treat infectious rhinitis. This article evaluates the use of a new form of the silver proteinatedrug, the drug is available in the pharmacy, easy to use, long shelf life. This article describes the place of silver proteinate among drugs that help to relieve the symptoms of acute nasopharyngitis and provides data on its effectiveness, safety and features of use in children. The drug can take a worthy place among topical drugs due to its high efficiency in the treatment of acute rhinitis and its possible use at any age.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference32 articles.

1. Osidak L.V., Dondurey E.A., Obraztsova E.V., Golovacheva E.G., Afanasieva O.I. Morbidity pattern and modern approaches to ARVI treatment in children. RMZh. Meditsinskoe obozrenie = RMJ. Medical Review. 2019;(3):33–38. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Struktura_zabolevaemosti_i_sovremennye_podhody_k_terapii_ORVI_u_detey.

2. Svisushkin V.M., Nikiforova G.N., Vlasova N.P. Opportunities of treating patients with ARVI at present. Lechashchiy vrach = Lechaschi Vrach Journal. 2013;(1):52–55. (In Russ.) Available at: https://www.lvrach.ru/2013/01/15435605.

3. Kochetkov P.A., Meytel’ I.Yu. Prevention and treatment of acute viral infections of the upper airways and their bacterial complications. RMZh. Otorinolaringologiya = RMJ. Otorhinolaryngology. 2016;(4):231–235. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Profilaktika_i_lechenie_ostryh_virusnyh_infekciyverhnih_dyhatelynyh_putey_i_ih_bakterialynyh_osloghneniy/#ixzz6YwETbdxl.

4. Kryukov A.I., Kunelskaya N.L., Izotova G.N., Gurov A.V., Yushkina M.A., Sokolov S.A. Approaches to acute rhinitis therapy. Meditsinskiy sovet = Medical Council. 2016;(9):45–47. (In Russ.) doi: 10.21518/2079-701X-2016-9-45-47.

5. Grüber C., Keil T., Kulig M., Roll S., Wahn U., Wahn V. History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol. 2008;19(6):505–512. doi: 10.1111/j.1399-3038.2007.00688.x.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3